The vaginal microbiota plays a crucial role in women's health, maintaining a delicate balance of microorganisms that can influence various aspects of reproductive health and immunity. Probiotics, comprising beneficial bacteria strains like Lactobacillus species, can help reinforce this balance by promoting the growth of beneficial bacteria and inhibiting harmful pathogens. They have shown promise in preventing and managing conditions like bacterial vaginosis and urinary tract infections. Prebiotics, on the other hand, act as fuel for these beneficial bacteria, aiding in their growth and activity within the vaginal ecosystem. Together, probiotics and prebiotics offer a holistic approach to supporting vaginal health, potentially reducing the incidence of infections and promoting overall well-being. Understanding and harnessing the synergy between these components hold significant potential for women's reproductive health.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India